January 31, 2001
Vol. 2, No. 4
Bruce Maxwell, Editor - firstname.lastname@example.org
Silver Hammer Publishing - http://silverhammerpub.com
Instructions for subscribing and unsubscribing are provided at
the end of this newsletter.
DRUGS THAT MAY DELAY ALZHEIMER'S FACE TEST OVER
A massive, seven-year clinical trial has been launched to see
whether the common pain drugs Aleve and Celebrex might delay the
onset of Alzheimer's disease. Researchers hope the
anti-inflammatory drugs will slow down the inflammation that
appears to damage or kill nerve cells in people with Alzheimer's.
Source: Boston Globe - Jan. 29, 2001
F.D.A. PULLS A DRUG, AND PATIENTS DESPAIR
For some people suffering from irritable bowel syndrome, the drug
Lotronex was the only thing that allowed them to lead normal
lives. But the drug was recalled in November after some patients
developed serious side effects and a few died. Now, many IBS
patients are demanding that the U.S. Food and Drug Administration
reinstate the drug, saying they're willing to accept the risks
associated with taking it.
Source: New York Times - Jan. 30, 2001
SHOCK AND DISBELIEF
This article takes a lengthy look at the pluses and minuses of
electroconvulsive therapy (ECT) for the treatment of severe
depression and other mental disorders. The article concludes that
despite strong opposition from the Church of Scientology and
others, ECT treatments have been refined and help many patients
who do not benefit from other treatments.
Source: Atlantic Monthly - February 2001
REPAIRING THE DAMAGE
If you've abused your body over the years by smoking, drinking
too much, eating too much, or not getting enough exercise, you
can get surprising, immediate benefits from lifestyle changes.
This article tells you how.
Source: Time Magazine - Feb. 5, 2001
NEW SURGERY CALLED LESS INVASIVE FOR
A new surgery called laparoscopic prostatectomy has a far faster
recovery period than the traditional operation to remove a man's
cancerous prostate. It's too early to tell whether it also causes
fewer incontinence and impotence problems than the traditional
operation, but some doctors are hopeful it will.
Source: Boston Globe - Jan. 26, 2001
U.S. DRUG COMPANIES HELP PAY FOR BUSH
The U.S. pharmaceutical industry contributed $1.7 million toward
the cost of President George W. Bush's inauguration. That's 10
percent of the estimated cost of the event.
Source: British Medical Journal - Jan. 27, 2001
AD CAMPAIGN HAS PARENTS ASKING FOR A COSTLY DRUG
A virus known by its initials R.S.V. infects almost every child,
usually causing symptoms that are comparable to a cold but
sometimes causing very serious illness and even death. The maker
of a drug that treats R.S.V. is targeting parents with scary ads
for its drug, which costs $5,000 for the required treatment.
Source: New York Times - Jan. 31, 2001
FEDS OK TESTS OF ARTIFICIAL HEART
The U.S. Food and Drug Administration has approved experimental
use in humans of a new artificial heart that's battery powered.
The two-pound pump will be implanted in five patients who are too
sick for heart transplants. The new device is said to be far more
advanced than the Jarvik-7, an artificial heart that was
introduced in the early 1980s but eventually recalled.
Source: Associated Press - Jan. 31, 2001
Will You Do Me a Favor?
If you find this newsletter useful, will you please forward it to
your friends, relatives, or colleagues who might like it? This is
the best way for me to gain subscribers so I can continue
publishing this free resource. Thanks very much for your support.
Copyright 2000 Silver Hammer Publishing. All rights reserved
worldwide. Please feel free to forward this newsletter to anyone
who might be interested, as long as you forward the entire
publication. However, it is expressly forbidden to post this
newsletter on any Web site or other electronic retrieval system.
To subscribe to Health Newsbrief, send a blank e-mail to
or visit the Web site.
Health Newsbrief Web page - http://silverhammerpub.com/hn.html
Advertising information - http://silverhammerpub.com/ad.html
Like this newsletter? Then subscribe to its sister newsletter,
HealthESites, which summarizes the latest news about health
information on the Internet and how the Internet is being used in
healthcare. Subscription info at http://silverhammerpub.com
Silver Hammer Publishing
6937 Custis Parkway
Falls Church, VA 22042
Newsbrief Main Page